Market Overview - The Chinese medical device market is expected to grow to 1.66 trillion yuan by 2030, with significant growth potential in the medical consumables sector[2] - The global medical device industry reached a total scale of $47.936 billion in 2023, projected to grow to $63.796 billion by 2028[2][7] - By 2025, China's medical device market is anticipated to reach 1.2442 trillion yuan, with a compound annual growth rate (CAGR) of 14.76% from 2017 to 2024[9] Medical Consumables Insights - In 2024, the medical consumables market in China is expected to account for 63.18% of the total medical device market, with a market size of approximately 595 billion yuan[14] - The high-value medical consumables market in China grew from 60.2 billion yuan in 2015 to 250.4 billion yuan in 2024, reflecting a CAGR of 17.2%[15] - The vascular intervention consumables segment is the largest, projected to reach about 91.8 billion yuan in 2024, representing 36.7% of the high-value consumables market[15] Market Performance - The median stock price change for the North Exchange's consumer service sector was -3.78% from March 23 to March 27, 2026, with 7% of companies experiencing an increase[37] - The total market capitalization of the North Exchange consumer service sector decreased from 100.036 billion yuan to 95.322 billion yuan during the same period[41] - The median price-to-earnings (P/E) ratio for the North Exchange consumer service sector fell from 37.5X to 36.5X[40] Company Announcements - Yisheng Mushrooms reported a revenue of 739.29 million yuan for 2025, a year-on-year increase of 19.91%, but a net profit decline of 23.05%[54] - The company plans to distribute a cash dividend of 5.00 yuan per 10 shares, totaling approximately 51.52 million yuan[54]

Market Performance - The North Exchange 50 Index saw a weekly increase of +0.58% from February 9 to February 13, 2026[3] - The average daily trading volume on the North Exchange was approximately CNY 18.575 billion, with a total trading volume of CNY 92.876 billion and a turnover rate of 16.85% during the same period[4][5] - The overall price-to-earnings (P/E) ratio for the North Exchange was approximately 46.94 times, which is higher than the ChiNext's 45.74 times but lower than the Sci-Tech Innovation Board's 78.61 times[21] Sector Performance - Among the 294 listed companies on the North Exchange, 103 companies had positive weekly growth, with the highest being Aide Technology (+144.72%) and Haiseng Medical (+133.86%)[10] - The media sector experienced a significant increase of +22.6%, while the oil and petrochemical sector saw a decline of -8.7%[10] Financing and Regulatory Measures - The North Exchange introduced a comprehensive package of measures to optimize refinancing, focusing on supporting quality listed companies and innovative small and medium-sized enterprises[40] - Key measures include improving the review process for quality companies, enhancing inclusivity for innovative SMEs, simplifying disclosure requirements, and strengthening regulatory oversight[41] Investment Strategy - The recommended investment strategy for 2026 emphasizes focusing on new productive forces in sectors such as renewable energy, intelligent manufacturing, and emerging consumption industries[27] - A bottom-up approach based on financial metrics is advised, targeting companies with high growth potential and strong R&D investment[27] Risk Factors - Potential risks include lower-than-expected policy support, rapid technological changes, and intensified market competition[3]

Group 1 - The three major indices collectively rose, with the ChiNext Index and the Sci-Tech 50 Index both increasing by over 1%. The total trading volume in the Shanghai and Shenzhen markets reached 2.16 trillion yuan, an increase of 159.7 billion yuan compared to the previous trading day [1] - The computing power industry chain experienced a collective surge, with significant gains in computing power leasing concepts. Major companies like Dazhi Technology and Capital Online saw their stocks hit the daily limit [1] - The Ministry of Industry and Information Technology announced plans to develop national computing power interconnection nodes, aiming to enhance the efficiency and service level of public computing resources and promote high-quality development in the computing power sector [1] Group 2 - The CPO concept saw rapid gains, with leading company Tianfu Communication's stock rising by 11.61% to a historical high of 322 yuan per share, bringing its market capitalization to 250.33 billion yuan [2] - The computing power chip concept also rose in the afternoon, with companies like Chipone Technology experiencing over a 10% increase in stock price [2] - The electric grid equipment sector showed strong performance, with companies like Siyuan Electric and Sifang Co. reaching new highs, while other companies in the sector also saw significant stock price increases [2]

Market Overview - On February 12, the three major indices collectively rose, with the ChiNext Index and the Sci-Tech Innovation 50 Index both increasing by over 1% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 2.16 trillion yuan, an increase of 159.7 billion yuan compared to the previous trading day [1] Index Performance - Shanghai Composite Index: 4134.02 (+2.03, +0.05%) [2] - Shenzhen Component Index: 14283.00 (+122.06, +0.86%) [2] - ChiNext Index: 1816.15 (+27.93, +1.56%) [2] - CSI 300: 4719.58 (+5.76, +0.12%) [2] - CSI 500: 8423.57 (+97.76, +1.17%) [2] Industry Developments - The Ministry of Industry and Information Technology announced plans to develop national computing power interconnection nodes, aiming to enhance the efficiency and service level of public computing resources [3] - Major domestic internet companies, including Tencent, Alibaba, and Baidu, are increasing efforts to attract users to AI applications, which is expected to significantly boost active user numbers in AI applications [3] - The demand for AI applications is driving growth in the domestic computing power industry chain, presenting key development opportunities [3] Stock Highlights - Tianfu Communication, a leader in the CPO concept, saw its stock rise by 11.61% to 322 yuan per share, reaching a market capitalization of 250.33 billion yuan [3] - Chip companies related to computing power also experienced gains, with Chipone Technology rising over 10% [3] - The liquid cooling server concept showed strong performance, with Chuanrun Co. achieving two consecutive trading limits in four days [3] - The electric grid equipment sector saw collective strength, with companies like Siyuan Electric and Sifang Co. reaching new highs [3] Individual Stock Movements - Double Good Energy, a solar energy company, saw its stock price hit the limit up within 10 minutes, with a total market value of 20.1 billion yuan, following the announcement of three overseas orders for high-efficiency heat exchangers [4] - Newly listed company N Haisheng experienced a maximum increase of 244.94%, triggering a trading halt, with over 300 million yuan in transactions [4]

Trading Activity - The average daily trading volume on the North Exchange decreased by 28.69% to 204.93 billion CNY, down from 287.38 billion CNY in the previous week[5] - The weekly turnover rate for the North Exchange was 19.15%, indicating a slight decline compared to previous weeks[7] Index Performance - The North 50 Index experienced a slight decline of 0.70% during the week, with fluctuations influenced by the weak performance of small-cap stocks[14] - Other indices such as the Sci-Tech 50 and the ChiNext Index saw declines of 5.76% and 3.28% respectively, highlighting a broader market downturn[14] Sector Analysis - Most sectors on the North Exchange reported negative median returns, with the beauty and personal care sector leading with a median increase of 2.32%, while the oil and petrochemical sector had the largest decline at -8.42%[20] - The computer industry had the highest median price-to-earnings (P/E) ratio at 139.57 times, indicating a relatively high valuation compared to other sectors[20] New Listings and Market Activity - There were two new IPOs on the North Exchange during the week, but no new stocks were listed[40] - The overall trading scale of the New Third Board decreased, with the innovative tier and basic tier seeing transaction amounts drop by 15.61% and 25.94% respectively[34] Risk Considerations - There is a noted risk of pullback in North Exchange stocks, particularly as trading volumes have shown signs of contraction, which may lead to further declines in the North 50 Index[42]

Trading Activity - The average daily trading volume on the North Exchange decreased by 28.69% to 204.93 billion CNY, down from 287.38 billion CNY in the previous week[5] - The weekly turnover rate for the North Exchange was 19.15%, indicating a decline in trading activity compared to previous weeks[7] Index Performance - The North 50 Index experienced a slight decline of 0.70% during the week, reflecting significant volatility in the market[14] - Other indices such as the Sci-Tech 50 and the ChiNext Index saw declines of 5.76% and 3.28% respectively, indicating a broader market downturn[14] Sector Analysis - Most sectors on the North Exchange reported negative median returns, with the beauty and personal care sector leading with a median increase of 2.32%, while the oil and petrochemical sector had the largest decline at -8.42%[20] - The computer industry had the highest median price-to-earnings (P/E) ratio at 139.57 times, indicating high valuation compared to other sectors[20] New Listings and Market Activity - There were two new IPOs on the North Exchange during the week, but no new stocks were listed[40] - The overall trading scale of the New Third Board decreased, with the innovative layer and basic layer trading amounts dropping by 15.61% and 25.94% respectively[34] Risk Considerations - There is a noted risk of pullback in North Exchange stocks, particularly as trading volumes have shown signs of contraction, which could lead to further declines in the North 50 Index[42]

Core Viewpoint - Haisheng Medical (920166) has been listed on the Beijing Stock Exchange, focusing on the development, production, and sales of anesthesia and monitoring medical devices, which are widely used in various clinical departments [1][2]. Company Overview - Haisheng Medical is a global provider of comprehensive products in the anesthesia and monitoring medical device sector, with its main business activities centered around the R&D, production, and sales of these medical devices [2]. - The company’s products are extensively applied in departments such as anesthesiology, ICU, and emergency medicine [2]. Shareholding Structure - Prior to the issuance, Huang Haisheng directly held 47.11% of the company's shares, making him the controlling shareholder. His spouse, Wu Xiaoye, holds a 20.60% stake in Lixin Investment, which indirectly controls 7.81% of the company’s shares [2]. - Together, Huang Haisheng and Wu Xiaoye control a total of 54.92% of the company's shares, confirming their status as the actual controllers of Haisheng Medical [2]. Fundraising Details - The total amount raised from this issuance is approximately 142.76 million yuan, with a net amount of about 113.44 million yuan [2]. - The raised funds are intended for upgrading and expanding production of anesthesia and monitoring emergency medical devices, establishing a R&D testing center, and building a marketing service base [2].

Group 1 - The core event is the listing ceremony of Zhejiang Haiseng Medical Equipment Co., Ltd. on the Beijing Stock Exchange, scheduled for February 12, 2026, from 09:00 to 09:30, with a live broadcast of the entire event [1][3] - Zhejiang Haiseng Medical Equipment Co., Ltd. was established in 2000 and specializes in the research, production, and sales of anesthesia and monitoring medical devices, serving global clinical needs in various departments such as anesthesia, ICU, and emergency [3] - The company is recognized as one of the early technology-driven manufacturers in China focusing on anesthesia and monitoring medical consumables and equipment, positioning itself as a leading enterprise in this niche market [3] Group 2 - The listing ceremony will include several segments: introduction of guests, speeches by leaders, ringing the listing bell, and a group photo session with guests [3]

Core Viewpoint - Zhejiang Haisheng Medical Devices Co., Ltd. is set to go public on the Beijing Stock Exchange, aiming to raise approximately 37 million yuan for the upgrade and expansion of its anesthetic and monitoring medical devices, as well as for the establishment of a research and testing center and a marketing service base [2]. Group 1: Company Overview - The company specializes in the research, production, and sales of anesthetic and monitoring medical devices, which are widely used in departments such as anesthesiology, ICU, and emergency [2]. - Huang Haisheng holds a 47.11% stake in the company, making him the controlling shareholder, while his spouse, Wu Xiaoye, indirectly controls an additional 7.81% through Lixin Investment, resulting in a combined control of 54.92% [2]. Group 2: IPO Details - The company plans to issue shares at a price of 12.64 yuan per share, with an expected earnings per share (EPS) ratio of 13.99, aligning with the specialized equipment manufacturing industry [1]. - The total number of shares to be issued is 11.2941 million, with 10.1647 million shares available for online subscription [1]. - The expected total fundraising amount is 142.7577 million yuan, with a net amount of approximately 113.4382 million yuan after deducting estimated issuance costs of 29.3194 million yuan [2].

Group 1 - The company, Hai Sheng Medical, focuses on anesthesia and monitoring medical devices, with a total market value of 8.09 billion yuan and an issuance price of 12.64 yuan per share [2][3] - The company has established a product matrix for anesthesia, monitoring, and surgical care, holding 14 core technologies and recognized as a national-level "specialized and innovative" small giant enterprise [3] - The company's main products are widely used in over a thousand tertiary hospitals across the country, with recent revenue figures showing 3.06 billion yuan in 2023, reflecting a 14.25% increase from the previous year [3] Group 2 - The company, Yi Si Wei, is a leader in machine vision equipment for automotive manufacturing, with a total market value of 41.96 billion yuan and an issuance price of 55.95 yuan per share [4] - The founding team has a strong background in precision testing technology and equipment, contributing to the company's competitive edge in the industry [4] - The company is actively promoting machine vision applications in rail transit operations, with over 331 million yuan in orders as of September 2025 [4]